Tetrakit Technologies ApS

CVR42094943

Core data

Name
Tetrakit Technologies ApS
Address
Ole Maaløes Vej 3, 2200, København N
Founded
Feb 2, 2021
12 / 10
Locations (P-units)
1View locations
Website
https://tetrakit.com/
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of Tetrakit Technologies ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

The Company's primary activities consist of developing radiopharmaceuticals for the diagnosis and treatment of cancer.

Financials

Company financials
Reporting period
2025DKK
Gross profit
-1,516,604
Operating profit
-6,461,832
Profit before tax
-7,115,452
Net income
-5,712,478
Total assets
24,394,710
Equity
1,033,836
Avg. employees
7
2021–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
co*****@tetrakit.comShow full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

Founders

FounderRegistered as founderCurrent rolesOwnership
Christian Bernard Matthijs PoulieRegistered as founderFeb 2, 2021Current roles
—
Ownership
6.66–13.49 %Indirect via Tetrakit Holdings ApS
Umberto Maria BattistiRegistered as founderFeb 2, 2021Current roles
BoardManagement
Ownership
13.33–22.49 %Indirect via Tetrakit Holdings ApS
Vladimir ShalgunovRegistered as founderFeb 2, 2021Current roles
Board
Ownership
13.33–22.49 %Indirect via Tetrakit Holdings ApS

People

Andreas Tue Ingemann JensenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Matthias Manfred HerthRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Rune Wiik KristensenRoles
Board
TitlesBESTYRELSESMEDLEM
Umberto Maria BattistiRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Vladimir ShalgunovRoles
Board
TitlesBESTYRELSESMEDLEM

Auditor

Deloitte Statsautoriseret RevisionspartnerselskabAuditorJens SerupRoleState Authorised Public AccountantFromJul 1, 2026
Deloitte Statsautoriseret RevisionspartnerselskabAuditorNicolai Niemann DamtoftRoleState Authorised Public AccountantFromJul 1, 2026
Ownership66.67–89.99 %Voting rights66.67 %FromMar 6, 2024
Ownership10–14.99 %Voting rights10 %FromJun 29, 2026

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromJun 26, 2026

Ultimate owners

Andreas Tue Ingemann Jensen
13.33–22.49 %
Matthias Manfred Herth
13.33–22.49 %
Umberto Maria Battisti
Ownership through
13.33–22.49 %
Vladimir Shalgunov
Ownership through
13.33–22.49 %
BioInnovation Institute Fonden
Ownership through
Direct
10–14.99 %
Christian Bernard Matthijs Poulie
Ownership through
6.66–13.49 %
🇩🇪Gnosis Verwaltungsgesellschaft m.b.H.
Ownership through
Direct
5–9.99 %

Official sources